SEARCH

SEARCH BY CITATION

References

  • 1
    Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001; 32: 2639.
  • 2
    White DG, Zhao S, Sudler R et al. The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med 2001; 345: 114754.
  • 3
    Galofre J, Moreno A, Mensa J et al. Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia. Clin Infect Dis 1994; 18: 8738.
  • 4
    Zaidi E, Bachur R, Harper M. Non-typhi Salmonella bacteremia in children. Pediatr Infect Dis J 1999; 18: 10737.
  • 5
    Grisaru-Soen G, Wysoki MG, Keller N. Risk factors for development of nontyphoid Salmonella bacteremia. Clin Pediatr (Phila) 2004; 43: 8259.
  • 6
    Shimoni Z, Pitlik S, Leibovici L et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis 1999; 28: 8227.
  • 7
    Weinberger M, Andorn N, Agmon V, Cohen D, Shohat T, Pitlik SD. Blood invasiveness of Salmonella enterica as a function of age and serotype. Epidemiol Infect 2004; 132: 10238.
  • 8
    Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 1987; 66: 34988.
  • 9
    Ramos JM, Garcia-Corbeira P, Aguado JM, Arjona R, Ales JM, Soriano F. Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis 1994; 19: 77780.
  • 10
    Lee SC, Yang PH, Shieh WB, Lasserre R. Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin Infect Dis 1994; 19: 6936.
  • 11
    Hsu RB, Tsay YG, Chen RJ, Chu SH. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003; 36: 82934.
  • 12
    Cohen PS, O'Brien TF, Schoenbaum SC, Medeiros AA. The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med 1978; 89: 9312.
  • 13
    Benenson S, Raveh D, Schlesinger Y et al. The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am J Med 2001; 110: 603.
  • 14
    Fernandez Guerrero ML, Ramos JM, Nunez A, De Gorgolas M. Focal infections due to non-typhi Salmonella in patients with AIDS: report of 10 cases and review. Clin Infect Dis 1997; 25: 6907.
  • 15
    Chiu CH, Lin TY, Ou JT. Predictors for extraintestinal infection of non-typhoidal Salmonella in patients without AIDS. Int J Clin Pract 1999; 53: 1614.
  • 16
    Chiu CH, Lin TY, Ou JT. Prevalence of the virulence plasmids of nontyphoid Salmonella in the serovars isolated from humans and their association with bacteremia. Microbiol Immunol 1999; 43: 899903.
  • 17
    Threlfall EJ, Hall ML, Rowe B. Salmonella bacteraemia in England and Wales, 1981–1990. J Clin Pathol 1992; 45: 346.
  • 18
    Ko WC, Yan JJ, Yu WL et al. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis. Clin Infect Dis 2005; 40: 3158.
  • 19
    Sun HY, Tseng SP, Hsueh PR et al. Occurrence of ceftriaxone resistance in ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates causing recurrent infection. Clin Infect Dis 2005; 40: 2089.
  • 20
    Lee CY, Chiu CH, Chuang YY et al. Multidrug-resistant non-typhoid Salmonella infections in a medical center. J Microbiol Immunol Infect 2002; 35: 7884.
  • 21
    Chiu CH, Wu TL, Su LH, Liu JW, Chu C. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000–2003. Emerg Infect Dis 2004; 10: 16746.
  • 22
    Wayne PN. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 15th informational supplement. CLSI document M100S15. Villanova: CLSI, 2005.
  • 23
    Yu VL, Chiou CC, Feldman C et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37: 2307.
  • 24
    Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 12506.
  • 25
    Chen YH, Chen TP, Lu PL et al. Salmonella choleraesuis bacteremia in southern Taiwan. Kaohsiung J Med Sci 1999; 15: 2028.
  • 26
    Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 1971; 50: 97112.
  • 27
    Specht EE. Hemoglobinopathic salmonella osteomyelitis. Orthopedic aspects. Clin Orthop Relat Res 1971; 79: 1108.
  • 28
    Lim E, Koh WH, Loh SF, Lam MS, Howe HS. Non-thyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001; 10: 8792.
  • 29
    Taylor G, Goodfield MJ. Fatal salmonellosis in systemic lupus erythematosus. Clin Exp Dermatol 1995; 20: 2557.
  • 30
    Chiu CH, Wu TL, Su LH et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med 2002; 346: 4139.
  • 31
    Chiu S, Chiu CH, Lin TY. Salmonella enterica serotype Choleraesuis infection in a medical center in northern Taiwan. J Microbiol Immunol Infect 2004; 37: 99102.
  • 32
    Kauffmann F. Classification of bacteria. A realistic scheme with special reference to the classification of Salmonella and Escherichia species. Copenhagen: Munksgaard, 1975.
  • 33
    Su LH, Chiu CH, Kuo AJ et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983–1999. Epidemiol Infect 2001; 127: 20713.